Topper James N's Form 4 filing
Phathom Pharmaceuticals, Inc. (PHAT) · filed May 13, 2025
- Accession no.
- 0001415889-25-012770
- Filed
- May 13, 2025
- Trade date
- May 9-12, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $152.8K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Topper James NCIK 0001341382 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 9, 2025 | Common Stock | PPurchaseAcquired | +33,376 | $3.19 | +$106,469.44 | 33,376 | Indirect | |
| May 9, 2025 | Common Stock | PPurchaseAcquired | +2,226 | $3.62 | +$8,058.12 | 35,602 | Indirect | |
| May 12, 2025 | Common Stock | PPurchaseAcquired | +12,601 | $3.04 | +$38,307.04 | 48,203 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.